Edwards Lifesciences upgraded to Buy from Hold at Stifel
Stifel analyst Rick Wise upgraded Edwards Lifesciences (EW) to Buy from Hold with a price target of $90, up from $75. The firm said that TAVR, ...
Stifel raises Edwards Lifesciences stock to buy, target to $90
Stifel analysts upgraded Edwards Lifesciences (NYSE:EW) stock from Hold to Buy, citing potential growth acceleration in the Transcatheter Aortic Valve Replacement (TAVR) market. The firm also ...
Analysts Conflicted on These Healthcare Names: Zimmer Biomet Holdings (ZBH), Merit Medical Systems (MMSI) and Elanco Animal Health (ELAN)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zimmer Biomet Holdings (ZBH – Research ...
Crowdfund Insider18h
OurCrowd Recognized Again as Most Active Venture Investor in Israel, Once Again: 68 Exits to Date
Online investment platform OurCrowd has once again been recognized as the most active venture investor in Israel - which ...
Globus Medical stock soars to all-time high of $93.68
Globus Medical Inc. (NYSE:GMED) shares have reached an unprecedented peak, touching an all-time high of $93.68. With a market capitalization of $12.7 billion and an impressive revenue growth of 102.1% ...
Indiatimes12h
Eris Lifesciences Share Price
Eris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 15,697.07 Crore) operating in Pharmaceuticals sector. Eris Lifesciences Ltd. key Products/Revenue ...